Bellerophon Therapeutics Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2014

Location

Warren NJ US

Primary Industry

Biotechnology

About

Established in 2014 and based in New Jersey, US, Bellerophon Therapeutics Inc. operates as a biotherapeutics company that produces and develops treatment and medicine for cardiopulmonary diseases.

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Cardiology, Pharmaceutical Research & Development

Website

www.bellerophon.com

Verticals

Manufacturing

Company Stage

Mature

Total Amount Raised

Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin

31 Dec 2014

(59,753,000)

(59,365,000)

(59,674,000)

31 Dec 2015

(46,568,000)

(46,191,000)

(46,459,000)

31 Dec 2016

(23,757,000)

(23,323,000)

(23,814,000)

31 Dec 2017

(24,599,000)

(24,232,000)

(54,818,000)

31 Dec 2018

(27,880,000)

(27,518,000)

2,814,000

31 Dec 2019

(17,473,000)

(17,125,000)

(13,267,000)

31 Dec 2020

31 Dec 2021

31 Dec 2022

Unlock the recent years of financials and more for Bellerophon Therapeutics Inc..

Request a demo to see more.

Employee Data

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.